. 1960 Jan 15:16:20-2.

[First experiments in hemicrania and epilepsy with 1-methyl-lysergic acid butanolamide, a substance with antiserotonin effects]

[Article in Italian]

[Article in Italian]

F SICUTERI. Prog Med (Napoli). 1960.

. 1960 Jan 15:16:20-2.

No abstract available

Similar articles

Prophylactic and therapeutic properties of 1-methyl-lysergic acid butanolamide in migraine.
SICUTERI F. SICUTERI F. Int Arch Allergy Appl Immunol. 1959;15:300-7. doi: 10.1159/000229055. Int Arch Allergy Appl Immunol. 1959. PMID: 14446408 No abstract available.
Evaluation of UML-491 in the treatment of vascular headaches. An analysis of the effects of 1-methyl-D-lysergic acid (plus) butanolamide bimaleate (methysergide).
FRIEDMAN AP, LOSIN S. FRIEDMAN AP, et al. Arch Neurol. 1961 Mar;4:241-5. doi: 10.1001/archneur.1961.00450090007002. Arch Neurol. 1961. PMID: 13701987 No abstract available.
Identification of antiepileptic properties of a lysergic-acid-derivative-UML 491-serotonin antagonist; preliminary report.
SICUTERI F. SICUTERI F. Med Exp Int J Exp Med. 1960;2:36-9. doi: 10.1159/000134839. Med Exp Int J Exp Med. 1960. PMID: 14446407 No abstract available.
Antagonism between an antiserotonin-the butanolamide of 1-methyl-lysergic acid--and the effects of a histamine-liberating substance 48/80 B. W. in man.
SICUTERI F, MICHELACCI S, FRANCHI G. SICUTERI F, et al. Int Arch Allergy Appl Immunol. 1959;15:291-9. doi: 10.1159/000229054. Int Arch Allergy Appl Immunol. 1959. PMID: 14446403 No abstract available.
[Migraine and epilepsy].
Tsuji S. Tsuji S. Rinsho Shinkeigaku. 2014;54(12):1003-5. doi: 10.5692/clinicalneurol.54.1003. Rinsho Shinkeigaku. 2014. PMID: 25672693 Review. Japanese.